Middle European Scientific Bulletin
Full Lenght Article
Features of Prescribing Modern Sugar-Lowering Drugs to Patients with Type 2 Diabetes Mellitus
Published 13 June 2022
Abstract
The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diabetes Atlas 2021, there are 536 million people with type 2 diabetes worldwide. At the same time, experts say that the number of undiagnosed diabetes mellitus (DM) may exceed the level recorded today by 2-3 times. Therefore, rational pharmacotherapy of this disease is the subject of numerous scientific and clinical studies. One of the largest recent studies has been the UK Diabetes Control and Complications Prospective Study (UKPDS). It lasted for about 20 years more than 5000 patients with type 2 diabetes participated in it. Patients were divided into groups who received different types of treatment since the moment of DM detection: only diet, various oral hypoglycemic drugs, insulin therapy.
Abstract
The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diabetes Atlas 2021, there are 536 million people with type 2 diabetes worldwide. At the same time, experts say that the number of undiagnosed diabetes mellitus (DM) may exceed the level recorded today by 2-3 times. Therefore, rational pharmacotherapy of this disease is the subject of numerous scientific and clinical studies. One of the largest recent studies has been the UK Diabetes Control and Complications Prospective Study (UKPDS). It lasted for about 20 years more than 5000 patients with type 2 diabetes participated in it. Patients were divided into groups who received different types of treatment since the moment of DM detection: only diet, various oral hypoglycemic drugs, insulin therapy.
Keywords
Declarations
Conflict of Interest Statement
The author (s) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Copyright and permissions
Copyright (c) 2022 Badridinova B. K.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
References
2. American Diabetes Association. “Standards of medical care in diabetes 2018”. Diabetes care 41. Suppl 1: s1-s159. Http://care.diabetesjournals.org/content/41/Supplement_1/S1
3. American Diabetes Association. “Standards of medical care in diabetes—2018 abridged for primary care providers.” Clinical Diabetes 36.1 (2018): 14-37. Http://clinical.diabetesjournals.org/content/36/1/14
4. Khafiza I. ZHURAEVA,Barno K. BADRIDINOVA,Khilola Sh. YAKHOYEVA,Mehriban Akhmadovna RIZAEVA. (2021). Peculiarities of the course of joint syndrome in persons with type 2 diabetes mellitus. Journal of Natural Remedies, 22(1(1), 92-98. Retrieved from http://www.jnronline.com/ojs/index.php/about/article/view/770
5. Dedov I.I., Melnichenko G.A., M. Algorithms of specialized medical care for patients with diabetes mellitus, edition 4 supplemented, ed.: Informpolygraph LLC, 2019. - 104 p.
6. Dedov, I.I., M.V. Shestakova. Diabetes mellitus: a guide for doctors M., Universum Publishing, 2013. - 455 p.
7. IDF Diabetes Atlas 2021 – 10th edition.
8. Firuza Takhirova, Nodira Alikhanova; Diabetes mellitus in the Tashkent region of Uzbekistan/Endocrine Abstracts (2022) 81 EP1189.
9. Firuza Takhirova, Nodira Alikhanova, Vol. 2 No. 1 (2022): British Medical Journal.
Bibliographic Information
Cite this article as:
-
Submitted
14 June 2022 -
Revised
14 June 2022 -
Published
13 June 2022